# AGIOS PHARMACEUTICALS INC (AGIO)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AGIO/

- Reporting holders: 4
- Reported value: $111.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $66.5K | 2,001 | 0.0% | 6 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $21.2K | 638 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $14.0K | 422 | 0.0% | 12 |
| [Bullock Wealth Management Group](https://holderbook.com/funds/2067581-bullock-wealth-management-group/) | $9.4K | 288 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $111.1K |
| Q2 2026 | 239 | $2.9B |
| Q1 2026 | 235 | $2.3B |
| Q4 2025 | 240 | $1.9B |
| Q3 2025 | 229 | $2.7B |
| Q2 2025 | 219 | $2.1B |
| Q1 2025 | 222 | $1.8B |
| Q4 2024 | 227 | $2.0B |
| Q3 2024 | 211 | $2.7B |
| Q2 2024 | 209 | $2.6B |
| Q1 2024 | 191 | $2.0B |
| Q4 2023 | 171 | $1.4B |